CUV

CLINUVEL PHARMACEUT.

• The Motley Fool·07/02 05:09

  This ASX biotech stock is tipped to double or even triple in value

• ASX·07/02 01:36

  CLINUVEL confirms terms of CEO's Employment Agreement-CUV.AX

• The Motley Fool·06/16 02:32

  Why Clinuvel, Elevra Lithium, Regis Resources, and SCEE shares are racing higher today

• ASX·06/15 23:06

  CLINUVEL publicly files 20-F to U.S. SEC-CUV.AX

• ASX·06/01 23:27

  CLINUVEL US Non-Deal Roadshow Presentation-CUV.AX

• The Motley Fool·05/24 23:53

  Bell Potter says this ASX 300 share could rise 80%+

• Dow Jones·05/24 22:35

  *Clinuvel Pharmaceuticals Price Target Cut 11% to A$17.00/Share by Bell Potter

• ASX·05/07 01:47

  Notification regarding unquoted securities - CUV

• The Motley Fool·04/28 04:34

  This ASX biotech is pushing for a Nasdaq listing. Could it reignite investor interest?

• ASX·04/28 00:00

  CLINUVEL update on Level II ADR upgrade, Nasdaq uplist

• The Motley Fool·04/27 00:53

  Guess which ASX 300 stock was given a big boost from the US FDA

• ASX·04/26 22:44

  FDA relaxes SCENESSE postmarketing requirement

• Dow Jones·04/24 06:06

  *Clinuvel Target Price Cut 3.2% to A$39.20/Share by Jefferies>CUV.AU

• ASX·04/23 22:57

  Final EMA scientific advice for pivotal Phase III vitiligo

• ASX·04/16 23:05

  Notification of cessation of securities - CUV